These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6401254)

  • 1. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
    Planas R; Arroyo V; Rimola A; Pérez-Ayuso RM; Rodés J
    Gastroenterology; 1983 Feb; 84(2):247-52. PubMed ID: 6401254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins.
    Daskalopoulos G; Kronborg I; Katkov W; Gonzalez M; Laffi G; Zipser RD
    Am J Kidney Dis; 1985 Oct; 6(4):217-21. PubMed ID: 3901735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of furosemide-induced natriuresis by acetylsalicylic acid in dogs.
    Berg KJ; Loew D
    Scand J Clin Lab Invest; 1977 Apr; 37(2):125-31. PubMed ID: 616038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure.
    Ginès A; Salmerón JM; Ginès P; Arroyo V; Jiménez W; Rivera F; Rodés J
    J Hepatol; 1993 Feb; 17(2):220-6. PubMed ID: 8445236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
    Salerno F; Borroni G; Lorenzano E; Solenghi D; Cazzaniga M; Bissoli F; Ceriani R; deFranchis R
    Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis.
    Mirouze D; Zipser RD; Reynolds TB
    Hepatology; 1983; 3(1):50-5. PubMed ID: 6401669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
    Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
    Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis.
    Pérez-Ayuso RM; Arroyo V; Camps J; Rimola A; Gaya J; Costa J; Rivera F; Rodés J
    Kidney Int; 1984 Jul; 26(1):72-80. PubMed ID: 6434791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Furosemide interaction with the prostaglandin and kallikrein-kinin systems of the kidneys].
    Kuz'min OB; Mikhaĭlenko PV; Kriukova RA
    Farmakol Toksikol; 1986; 49(2):21-4. PubMed ID: 2423364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative acute effects of diflunisal and indomethacin on renal function in patients with cirrhosis and ascites.
    Antillon M; Cominelli F; Reynolds TB; Zipser RD
    Am J Gastroenterol; 1989 Feb; 84(2):153-5. PubMed ID: 2916525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect, on renal function, of a product rich in polyunsaturated fatty acids: results obtained in healthy subjects].
    Bernardi P; Bastagli L; Pecoraro F; Vitolo A; Minelli C; Cavazza M; Adani C
    Boll Soc Ital Biol Sper; 1982 Jan; 58(1-2):55-9. PubMed ID: 6802154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate.
    Bianco S; Vaghi A; Pieroni MG; Robuschi M; Refini RM; Berni F; Sestini P
    Allergy; 1993 Nov; 48(8):570-5. PubMed ID: 8116856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intravenous amino acid infusion and dietary proteins on kidney function in cirrhosis.
    Badalamenti S; Ginés P; Arroyo V; Llach J; Piera C; Rimola A; Jiménez W; Gaya J; Casamitjana R; Rivera F
    Hepatology; 1990 Mar; 11(3):379-86. PubMed ID: 2312051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.